Zhang M, Campbell T, Falcon S, Wang J
Biocell. 2023; 47(10):2125-2132.
PMID: 37974562
PMC: 10651080.
DOI: 10.32604/biocell.2023.030161.
Park J, Kang G, Kim Y, Lee J, Song J, Hwang J
Sci Rep. 2022; 12(1):8149.
PMID: 35581361
PMC: 9114421.
DOI: 10.1038/s41598-022-12183-8.
Tang H, Li Y, Wang S, Ji J, Zhu X, Bao Y
iScience. 2022; 25(5):104209.
PMID: 35494252
PMC: 9046235.
DOI: 10.1016/j.isci.2022.104209.
Catherinet C, Passaro D, Gachet S, Medyouf H, Reynaud A, Lasgi C
PLoS One. 2021; 16(7):e0254184.
PMID: 34234374
PMC: 8263285.
DOI: 10.1371/journal.pone.0254184.
Jordan P, Andreas N, Groth M, Wegner P, Weber F, Jager U
Immunology. 2021; 164(3):541-554.
PMID: 34142370
PMC: 8517600.
DOI: 10.1111/imm.13386.
Role of NFAT in Chronic Lymphocytic Leukemia and Other B-Cell Malignancies.
Sana I, Mantione M, Angelillo P, Muzio M
Front Oncol. 2021; 11:651057.
PMID: 33869054
PMC: 8047411.
DOI: 10.3389/fonc.2021.651057.
Calcineurin inhibitors suppress acute graft-versus-host disease via NFAT-independent inhibition of T cell receptor signaling.
Otsuka S, Melis N, Gaida M, Dutta D, Weigert R, Ashwell J
J Clin Invest. 2021; 131(11).
PMID: 33822776
PMC: 8159692.
DOI: 10.1172/JCI147683.
Isoform-Selective NFAT Inhibitor: Potential Usefulness and Development.
Kitamura N, Kaminuma O
Int J Mol Sci. 2021; 22(5).
PMID: 33800389
PMC: 7962815.
DOI: 10.3390/ijms22052725.
Formaldehyde exposure induces regulatory T cell-mediated immunosuppression via calcineurin-NFAT signalling pathway.
Park J, Yang H, Song M, Kim D, Lee K
Sci Rep. 2020; 10(1):17023.
PMID: 33046725
PMC: 7550593.
DOI: 10.1038/s41598-020-72502-9.
Genetic inhibition of NFATC2 attenuates asparaginase hypersensitivity in mice.
Rathod S, Ramsey M, Finkelman F, Fernandez C
Blood Adv. 2020; 4(18):4406-4416.
PMID: 32931581
PMC: 7509855.
DOI: 10.1182/bloodadvances.2020002478.
Two Birds with One Stone: NFAT1-MDM2 Dual Inhibitors for Cancer Therapy.
Wang W, Zafar A, Rajaei M, Zhang R
Cells. 2020; 9(5).
PMID: 32397368
PMC: 7291050.
DOI: 10.3390/cells9051176.
An intronic polymorphism of gene shows a risk association with biopsy-proven acute rejection in renal transplant recipients.
Wang Z, Zhang H, Yang H, Zheng M, Guo M, Chen H
Ann Transl Med. 2020; 8(5):211.
PMID: 32309358
PMC: 7154465.
DOI: 10.21037/atm.2020.01.61.
TCR Dependent Metabolic Programming Regulates Autocrine IL-4 Production Resulting in Self-Tuning of the CD8 T Cell Activation Setpoint.
Crofts K, Holbrook B, Soto-Pantoja D, Ornelles D, Alexander-Miller M
Front Immunol. 2020; 11:540.
PMID: 32300344
PMC: 7145404.
DOI: 10.3389/fimmu.2020.00540.
Targeted deletion of NFAT-Interacting-Protein-(NIP) 45 resolves experimental asthma by inhibiting Innate Lymphoid Cells group 2 (ILC2).
Koch S, Knipfer L, Kolle J, Mirzakhani H, Graser A, Zimmermann T
Sci Rep. 2019; 9(1):15695.
PMID: 31666531
PMC: 6821848.
DOI: 10.1038/s41598-019-51690-z.
NFAT primes the human RORC locus for RORγt expression in CD4 T cells.
Yahia-Cherbal H, Rybczynska M, Lovecchio D, Stephen T, Lescale C, Placek K
Nat Commun. 2019; 10(1):4698.
PMID: 31619674
PMC: 6795897.
DOI: 10.1038/s41467-019-12680-x.
Acute 4,4'-Methylene Diphenyl Diisocyanate Exposure-Mediated Downregulation of miR-206-3p and miR-381-3p Activates Inducible Nitric Oxide Synthase Transcription by Targeting Calcineurin/NFAT Signaling in Macrophages.
Lin C, Law B, Hettick J
Toxicol Sci. 2019; 173(1):100-113.
PMID: 31609387
PMC: 6944756.
DOI: 10.1093/toxsci/kfz215.
NFAT1 protects articular cartilage against osteoarthritic degradation by directly regulating transcription of specific anabolic and catabolic genes.
Zhang M, Lu Q, Budden T, Wang J
Bone Joint Res. 2019; 8(2):90-100.
PMID: 30915215
PMC: 6397328.
DOI: 10.1302/2046-3758.82.BJR-2018-0114.R1.
Revisiting the Concept of Targeting NFAT to Control T Cell Immunity and Autoimmune Diseases.
Lee J, Kim L, Choi J
Front Immunol. 2018; 9:2747.
PMID: 30538703
PMC: 6277705.
DOI: 10.3389/fimmu.2018.02747.
NFATC2 is a novel therapeutic target for colorectal cancer stem cells.
Lang T, Ding X, Kong L, Zhou X, Zhang Z, Ju H
Onco Targets Ther. 2018; 11:6911-6924.
PMID: 30410349
PMC: 6199214.
DOI: 10.2147/OTT.S169129.
Circulating miRs-183-5p, -206-3p and -381-3p may serve as novel biomarkers for 4,4'-methylene diphenyl diisocyanate exposure.
Lin C, Law B, Siegel P, Hettick J
Biomarkers. 2018; 24(1):76-90.
PMID: 30074411
PMC: 6474405.
DOI: 10.1080/1354750X.2018.1508308.